Skip to main content
Menu

Posts tagged with "Who Discovers and Why"

  • Business and Markets

    Out of Ideas?

    The Wall Street Journal came out with a series of articles on innovation in the US, and the biopharma industry features quite a bit in them. The lead one is an overview, with the theme of “The US economy’s hidden problem is that we’re out of big ideas”, and there’s another one specifically on Sanofi… Read More
  • Graduate School

    Getting Going

    I’ve had a chance recently to talk to some people who are heading off to chemistry grad school in the fall, which brought back memories of when I did that a mere thirty-three years ago. A lot has changed over that time, but there are some very important things that haven’t. One of the most… Read More
  • Drug Industry History

    Company Time For Your Own Ideas, Or Not?

    Over the years, at many R&D-driven companies, there have been official/unofficial policies that researchers could spend some percent of their time pursuing their own ideas, versus their official projects and goals. You hear different figures, especially when it comes to past glories, but there are definitely companies that have made this a stat… Read More
  • Who Discovers and Why

    No Scientific Method, They Say

    Several people have sent this article along, and since there’s not a lot of news so far today, I thought I’d go into it a bit. The title is eye-catching: “There Is No Scientific Method”, but that contention is probably the least objectionable part of the whole thing. Physicist Chad Orzel thought so – his problem… Read More
  • Drug Development

    Grit And Giving Up, Experience and Ignorance

    It seems to be a fairly slow news day in biopharma – not always such a bad thing – so I wanted to bring up a general drug discovery question. Unfortunately, I’m not sure it has a good answer. What is the proper balance between perseverance and pragmatism – in other words, how do you… Read More
  • Business and Markets

    Startups In Other Parts of the Map

    I read this piece on venture capital with some interest, because it addresses a topic I’ve thought about (and which has come up several times on this blog): where startup companies get funded. It’s been clear for some time now that that the biopharma industry has been concentrating more and more in the San Francisco… Read More
  • Academia (vs. Industry)

    A Professor’s View On Drug Company Collaborations

    My post the other day on Phil Baran’s public-private funding ideas brought in a lot of comment. As usual, I encourage a look a the comments section if you’re interested in the topic, or any topic that comes up around here – a lot of people who know whereof they speak show up. But I… Read More
  • Academia (vs. Industry)

    Don’t Wait For the Public Sector

    If you haven’t seen this speech by Phil Baran, given at his induction into the American Academy of Arts and Sciences, it’s worth a look. His main theme is what organic chemists can learn from the business model of SpaceX, and he starts out by talking about how grant money for synthetic organic chemistry has… Read More
  • Who Discovers and Why

    The Story Behind the Story Behind the Story

    I enjoyed this article at FiveThirtyEight, because I’ve had similar thoughts over the years myself. There are layers of knowledge about many topics, and it can be hard to be sure what layer you’ve made it do, and whether there’s another one underneath you yet. The first example in the piece is the spinach-has-a-lot-of-iron idea… Read More
  • Book Recommendations

    Realizing That There Was Such a Thing as Science

    I’ve been enjoying this book, The Invention of Science by David Wootton, which was just published in the US back in December. It’s a history of the beginnings of the scientific revolution back in the 1500s and 1600s, and it takes a lot of issues with how that history has been told by some other authors. Read More
123...